Schroder Investment Management Group Buys 5,326 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Schroder Investment Management Group raised its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 2.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 210,833 shares of the company’s stock after acquiring an additional 5,326 shares during the period. Schroder Investment Management Group owned approximately 0.18% of Privia Health Group worth $4,105,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Rhumbline Advisers boosted its position in shares of Privia Health Group by 1.3% in the fourth quarter. Rhumbline Advisers now owns 287,200 shares of the company’s stock valued at $5,615,000 after acquiring an additional 3,658 shares during the period. Nordea Investment Management AB raised its position in shares of Privia Health Group by 33.1% in the fourth quarter. Nordea Investment Management AB now owns 349,773 shares of the company’s stock valued at $6,953,000 after buying an additional 86,910 shares in the last quarter. Franklin Resources Inc. boosted its stake in shares of Privia Health Group by 2.2% in the third quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company’s stock valued at $23,092,000 after buying an additional 28,480 shares during the period. Barclays PLC grew its position in Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock worth $4,079,000 after buying an additional 158,188 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company’s stock worth $3,430,000 after acquiring an additional 14,641 shares during the period. Institutional investors and hedge funds own 94.48% of the company’s stock.

Insider Buying and Selling at Privia Health Group

In other news, CFO David Mountcastle sold 5,630 shares of Privia Health Group stock in a transaction on Wednesday, April 2nd. The shares were sold at an average price of $22.38, for a total value of $125,999.40. Following the completion of the sale, the chief financial officer now owns 179,676 shares in the company, valued at $4,021,148.88. The trade was a 3.04 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 14.20% of the company’s stock.

Privia Health Group Price Performance

Shares of NASDAQ:PRVA opened at $21.97 on Friday. Privia Health Group, Inc. has a 1 year low of $15.92 and a 1 year high of $26.04. The business’s 50-day moving average is $23.78 and its 200-day moving average is $21.31. The company has a market capitalization of $2.65 billion, a price-to-earnings ratio of 219.72, a P/E/G ratio of 3.47 and a beta of 0.88.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Needham & Company LLC reiterated a “buy” rating and set a $30.00 target price on shares of Privia Health Group in a research report on Friday, March 21st. Macquarie assumed coverage on shares of Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. Canaccord Genuity Group boosted their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Stephens reiterated an “overweight” rating and issued a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Finally, JMP Securities set a $29.00 target price on shares of Privia Health Group in a report on Friday, February 28th. One equities research analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, Privia Health Group presently has an average rating of “Buy” and a consensus price target of $26.67.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.